HRTX Latest Press Releases

-- February 26, 2026 --

Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results Globe Newswire 8:00 AM

-- February 17, 2026 --

Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026 Globe Newswire 8:30 AM

-- January 9, 2026 --

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF Largest Contributor to Q4 Growth Globe Newswire 9:29 AM

-- December 4, 2025 --

Heron Therapeutics Announces Inclusion of APONVIE (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV) Globe Newswire 8:15 AM

-- November 4, 2025 --

Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress Globe Newswire 8:00 AM

-- October 29, 2025 --

Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors Globe Newswire 5:58 PM

-- October 21, 2025 --

Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 Globe Newswire 4:20 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software